27 Jan Annnouncements VAXIL PROVIDES UPDATE ON USAMRIID, ORAL EXPERIMENT AND OTHER GENERAL BUSINESS MATTERS … Read the rest Posted on January 27, 2021 by David Goren
02 Jan Annnouncements VAXIL’S ANNUAL AND SPECIAL SHAREHOLDERS MEETING AND UPDATE ON EXERCISE OF WARRANTS … Read the rest Posted on January 2, 2021 by David Goren
31 Dec Annnouncements VAXIL PROVIDES UPDATE ON USAMRIID AND ORAL EXPERIMENTS … Read the rest Posted on December 31, 2020 by David Goren
22 Dec Annnouncements VAXIL RETAINS INVESTOR ENGAGEMENT AND MARKETING FIRM … Read the rest Posted on December 22, 2020December 22, 2020 by David Goren
10 Dec Annnouncements VAXIL ANNOUNCES CLOSE OF SECOND AND FINAL TRANCHE OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT FOR GROSS PROCEEDS OF $264,100 – TOTAL GROSS PROCEEDS REACH $806,958 … Read the rest Posted on December 10, 2020 by David Goren
